Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
80 and over (1) 1
administration & dosage (1) 1
adverse effects (1) 1
aged (1) 1
aged, 80 and over (1) 1
alzheimer disease (1) 1
alzheimer disease - diagnosis (1) 1
alzheimer disease - drug therapy (1) 1
alzheimer disease - immunology (1) 1
alzheimer's disease (1) 1
amyloid beta-peptides (1) 1
amyloid beta-peptides - blood (1) 1
amyloid beta-protein (1) 1
analysis (1) 1
antibodies (1) 1
area under curve (1) 1
blood (1) 1
care and treatment (1) 1
clinical neurology (1) 1
clinical trials (1) 1
clinical-trials (1) 1
cognitive decline (1) 1
diagnosis (1) 1
dose-response relationship (1) 1
dose-response relationship, drug (1) 1
double-blind method (1) 1
drug (1) 1
drug therapy (1) 1
equipment and supplies (1) 1
female (1) 1
humans (1) 1
image processing (1) 1
imaging abnormalities (1) 1
immunoglobulins (1) 1
immunoglobulins, intravenous - administration & dosage (1) 1
immunoglobulins, intravenous - adverse effects (1) 1
immunoglobulins, intravenous - blood (1) 1
immunology (1) 1
immunotherapy (1) 1
index medicus (1) 1
intravenous (1) 1
male (1) 1
medical colleges (1) 1
middle aged (1) 1
mini-mental-state (1) 1
model (1) 1
neurology (1) 1
neurosciences (1) 1
neurovetenskaper (1) 1
placebos (1) 1
plasma (1) 1
progression (1) 1
severity of illness index (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial
by Dodel, Richard, Prof and Rominger, Axel, MD and Bartenstein, Peter, MD and Barkhof, Frederik, MD and Blennow, Kaj, PhD and Förster, Stefan, MD and Winter, Yaroslav, MD and Bach, Jan-Philipp, MD and Popp, Julius, MD and Alferink, Judith, MD and Wiltfang, Jens, MD and Buerger, Katharina, MD and Otto, Markus, MD and Antuono, Piero, MD and Jacoby, Michael, MD and Richter, Ralph, MD and Stevens, James, MD and Melamed, Isaac, MD and Goldstein, Jerome, MD and Haag, Stefan, MD and Wietek, Stefan, PhD and Farlow, Martin, MD and Jessen, Frank, MD and Sahlgrenska akademin and Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi and Göteborgs universitet and Gothenburg University and Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry and Sahlgrenska Academy
Lancet Neurology, ISSN 1474-4422, 2013, Volume 12, Issue 3, pp. 233 - 243
Summary Background Three small trials suggest that intravenous immunoglobulin can affect biomarkers and symptoms of mild-to-moderate Alzheimer's disease. We... 
Neurology | ANTIBODIES | MINI-MENTAL-STATE | COGNITIVE DECLINE | PLASMA | IMMUNOTHERAPY | IMAGING ABNORMALITIES | CLINICAL-TRIALS | MODEL | PROGRESSION | CLINICAL NEUROLOGY | Severity of Illness Index | Double-Blind Method | Area Under Curve | Humans | Middle Aged | Immunoglobulins, Intravenous - adverse effects | Alzheimer Disease - drug therapy | Immunoglobulins, Intravenous - administration & dosage | Male | Amyloid beta-Peptides - blood | Alzheimer Disease - diagnosis | Dose-Response Relationship, Drug | Aged, 80 and over | Placebos | Female | Aged | Alzheimer Disease - immunology | Immunoglobulins, Intravenous - blood | Medical colleges | Immunoglobulins | Care and treatment | Neurosciences | Image processing | Analysis | Amyloid beta-protein | Clinical trials | Equipment and supplies | Alzheimer's disease | Drug | drug therapy | Intravenous | diagnosis | Alzheimer Disease | blood | 80 and over | administration & dosage | Amyloid beta-Peptides | adverse effects | Dose-Response Relationship | immunology | Neurovetenskaper
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.